Use of U-500 regular insulin via continuous subcutaneous insulin infusion: Clinical practice experience

Journal of Diabetes Science and Technology

Volumn 5, Issue 4, 2011, Pages 1025-1026

  Reutrakul, Sirimon ^a   Brown, Rebecca L ^b   Koh, Chung Kay ^a   Hor, Tiffany K ^a   Baldwin, David ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Continuous subcutaneous insulin infusion; Insulin pump; Insulin resistance; U 500 regular insulin

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADULT; DIABETES MELLITUS; DOSE RESPONSE; DRUG DOSAGE FORM; EVALUATION; FEMALE; HUMAN; INSULIN INFUSION; LETTER; MALE; MIDDLE AGED; PROFESSIONAL PRACTICE; RETROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; DIABETES MELLITUS; DOSAGE FORMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; PROFESSIONAL PRACTICE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84855371133     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681100500429     Document Type: Letter

References (6)

1. Davidson MB, Navar MD, Echeverry D, Duran P. U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients. Diabetes Care. 2010;33(2):281-3.
2. Nayyar V, Lawrence IG, Kong MF, Gallagher A., Gregory R, Hiles S, Jackson S, McNally P, Davies MJ. Long-term follow-up of patietns on U-500 Human Actrapid in Leicestershire. Diabetologia. 2007;50 (Suppl 1):S395.
3. Lane WS, Weinrib SL, Rappaport JM, Przestrzelski T. A prospective trial of U500 insulin delivered by Omnipod in patients with type 2 diabetes mellitus and severe insulin resistance. Endocr Pract. 2010;16(5):778-84.
4. Bulchandani DG, Konrady T, Hamburg MS. Clinical efficacy and patient satisfaction with U-500 insulin pump therapy in patients with type 2 diabetes. Endocr Pract. 2007;13(7):721-5.
5. Knee TS, Seidensticker DF, Walton JL, Solberg LM, Lasseter DH. A novel use of U-500 insulin for continuous subcutaneous insulin infusion in patients with insulin resistance: a case series. Endocr Pract. 2003;9(3):181-6.
6. Lane WS, Cochran EK, Jackson JA, Scism-Bacon JL, Corey IB, Hirsch IB, Skyler JS. High-dose insulin therapy: is it time for U-500 insulin? Endocr Pract. 2009;15(1):71-9.